Skip to main content
Veterinary Medicines

GAMARET, intramamarna suspenzija za krave u laktaciji

Authorised
  • Prednisolone
  • Novobiocin sodium
  • Dihydrostreptomycin sulfate
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine

Product identification

Medicine name:
GAMARET, intramamarna suspenzija za krave u laktaciji
Active substance:
  • Prednisolone
  • Novobiocin sodium
  • Dihydrostreptomycin sulfate
  • NEOMYCIN SULFATE
  • Benzylpenicillin procaine
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Prednisolone
    10.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Novobiocin sodium
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    91250.00
    international unit(s)
    /
    10.00
    millilitre(s)
  • NEOMYCIN SULFATE
    102000.00
    international unit(s)
    /
    10.00
    millilitre(s)
  • Benzylpenicillin procaine
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Milk
        108
        hour
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/23-01/755
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 23/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."